Alzheimer's Assocation Research only
All of
  • Go to
  • Research Center
  • AAIC
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Videos and Media

Alzheimer's Association International Conference — "Ask the Expert" with David Knopman, M.D.

Is a brain autopsy still the only way to definitively diagnose Alzheimer's disease?

What are some of the biggest advancements in our understanding of Alzheimer's in the past couple of years? Are we getting close to a cure?

If it can be determined that Alzheimer's starts around 20 years before symptoms begin, is there an opportunity to treat it before symptoms starts?

Are there promising results for any drugs currently being investigated for treating Alzheimer's?

Why is the rate of decline for some people with Alzheimer's so much faster than others?

Finding a cure is the ultimate goal.  The World Dementia Council and other U.S. organizations have set a goal of accomplishing this by 2025. What are your thoughts on this goal?

What do you think about the use of ultrasound as a treatment for Alzheimer's? A recent study with laboratory animals appeared to show promise.

About David Knopman, M.D.: Dr. Knopman earned his M.D. degree from the University of Minnesota (UM) Medical School, where he also completed his neurology residency. This was followed by a fellowship in behavioral neurology at Hennepin County Medical Center and UM. He was a faculty member at the University of Minnesota from 1980 to 2000. Dr. Knopman joined the Department of Neurology at the Mayo Clinic, Rochester, Minnesota, in 2000, where he is currently professor of neurology, Mayo Clinic College of Medicine, a consultant in Neurology at the Mayo Clinic, and a co-investigator in the Mayo Alzheimer's Disease Research Center. His research and clinical interests have been in dementing illnesses. He is an author on more than 300 articles on various topics in dementia. Dr. Knopman is deputy editor of Neurology, the journal of the American Academy of Neurology (AAN). He was the senior author on the 2001 AAN Practice Parameter on the Diagnosis of Dementia and was co-chair of the National Institute of Aging-Alzheimer's Association workgroup that drafted the revised criteria for Alzheimer's disease dementia. Dr. Knopman joined the Alzheimer's Association Medical and Scientific Advisory Council in 2012.


Alzheimer's Association International Conference | July 16-20, 2017, London, England

Abstract Submissions Now Open

The Scientific Program Committee is now accepting submissions for poster
presentations, oral presentations and featured research sessions.